JPRN-UMIN000009643已完成2 期
Phase II trial of perioperative chemotherapy with cisplatin and dose dense paclitaxel in patients with stage IB2,IIA2 orIIB uterine cervical cancer SGSG014 - Phase II trial of perioperative dose dense TP in patients with stage IB2,IIA2,IIB uterine cervical cancer (SGSG014)
Sankai Gynecology Study Group0 个研究点目标入组 50 人开始时间: 2012年12月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Usage of other experimental drugs, phenytoin or flucytosine 2) History of serious drug allergy or hypersensitivity with cisplatin or paclitaxel 3) Massive ascites, ileus 4) Active infection 5) Peripheral neuropathy grade 2-4 6) Unstable angina, myocardinal infarction within 6 months or serious arrthymia 7) Interstitial pneumonia or fibrosis 8) Double cancer 9) No coexisting severe medical conditions such as uncontrollable diabetes mellitus, hypertension or bleeding 10) Pregnancy or lactation 11) Mental disease 12) Continuus usage of steroid 13) Bilateral hydronephrosis 14) Judged as inappropriate to participate this trial by investigators
研究者
相似试验
已完成
不适用
Phase II trial of perioperative chemotherapy with cisplatin and dose dense paclitaxel in patients with stage Ib2-IIb uterine cervical cancer (SGSG013)JPRN-UMIN000006440Sankai Gynecology Study Group50
尚未招募
不适用
A phase II trial of preoperative chemotherapy with capecitabine plus short-course radiotherapy for resectable T3 rectal cancerJPRN-UMIN000016518Meiwa Hospital60
已完成
2 期
Clinical trial of postoperative chemotherapy with TS-1 in recurrent high-risk cases with oral squamous cell carcinomaOral squamous cell carcinomaJPRN-UMIN000009628Department of Clinical Oral Oncology, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences90
已完成
2 期
Phase II trial of perioperative chemotherapy for esophageal canceresophageal cancerJPRN-UMIN000020204Kyoto university hospital50
已完成
2 期
Phase II Trial of Preoperative Chemotherapy and Bevacizumab in Patients With Stage IIIA Non-Squamous Non-Small Cell Lung Canceron-squamous, Non-small cell lung cancerJPRN-UMIN000004487Osaka International Cancer Institute30